Physician profile
Craig Underset
NPI 1477519965
$356.80
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $53.76 · 2021: $90.55 · 2022: $16.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $73.93 | 2019 | |
| Novo Nordisk INC | $57.25 | 2019-2021 | |
| Abbvie INC. | $44.55 | 2021-2022 | |
| Amarin Pharma, INC. | $33.37 | 2019 | |
| Vertical Pharmaceuticals, LLC | $27.78 | 2019 | |
| Sanofi-Aventis U.S. LLC | $27.40 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.25 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.49 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.70 | 2021 | |
| Sanofi Pasteur INC. | $12.44 | 2019 | |
| Esperion Therapeutics, INC. | $12.21 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.18 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $8.25 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Underset listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.